A phase I, open label, study of the safety and tolerability of KU-0059436 and topotecan in the treatment of patients with advanced solid tumours.
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2010
At a glance
- Drugs Olaparib; Topotecan
- Indications Solid tumours
- Focus Adverse reactions
- 18 Apr 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 18 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Oct 2008 Planned end date changed from 1 Mar 2008 to 1 Dec 2008 as reported by ClinicalTrials.gov.